Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ. College of Medicine
Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ. College of Medicine
Seoul, South Korea1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer | Hormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC 1+ or 2+ & ISH Negative) | Recruiting | Phase 2 | 2025-04-29 | NCT06837792 |